Influence of FGF2 and PEG hydrogel matrix properties on hMSC viability and spreading

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 3, 2010, Pages 1110-1123

  King, William J ^a   Jongpaiboonkit, Leenaporn ^a   Murphy, William L ^a,b  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

bFGF; Extracellular matrix; Fibroblast growth factor; Mesenchymal stem cells; Poly(ethylene glycol); Tissue engineering

Indexed keywords

3-D ENVIRONMENTS; ARG GLY ASPS; AUTOPHOSPHORYLATION; DEGRADABILITY; DOSE-DEPENDENT MANNER; EXTRACELLULAR MATRICES; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR-2; HUMAN MESENCHYMAL STEM CELLS; HYDROGEL MATRIX; HYDROGEL NETWORKS; LIGAND DENSITY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELLS; PEG HYDROGEL; SMALL MOLECULES; STEM CELL;

ADHESION; BIOACTIVITY; CELL ADHESION; CELL CULTURE; ETHYLENE; ETHYLENE GLYCOL; FIBROBLASTS; LIGANDS; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; STEM CELLS; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING;

HYDROGELS;

ARGINYLGLYCYLSERYLPROLYLASPARTYLSERYLPROLINE LIGAND; FIBROBLAST GROWTH FACTOR 2; LIGAND; MACROGOL; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROGEL; MESENCHYMAL STEM CELL; MORPHOLOGY;

CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DIFFUSION; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYDROGEL; LIGANDS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; PEPTIDES; POLYETHYLENE GLYCOLS; SOLUBILITY;

EID: 77950681331     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32601     Document Type: Article

References (51)

1. Nuttelman CR, Tripodi MC, Anseth KS. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater Res A 2006;76:183-195.
2. Jongpaiboonkit L, King WJ, Murphy WL. Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A 2008;15:343-353.
3. Yang F, Williams CG, Wang DA, Lee H, Manson PN, Elisseeff J. The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials 2005;26:5991-5998. (Pubitemid 40805605)
4. Benoit DS, Anseth KS. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 2005;1:461-470.
5. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005;23:47-55.
6. Nuttelman CR, Tripodi MC, Anseth KS. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 2005;24:208-218.
7. Drury JL, Mooney DJ. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 2003;24:4337-4351. (Pubitemid 36960132)
8. Uludag H, De Vos P, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 2000;42:29-64.
9. Patel PN, Gobin AS, West JL, Patrick CW. Poly(ethylene glycol) hydrogel system supports preadipocyte viability, adhesion, and proliferation. Tissue Eng 2005;11:1498-1505.
10. Sharma B, Williams CG, Khan M, Manson P, Elisseeff JH. In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg 2007;119:112-120.
11. Williams CG, Kim TK, Taboas A, Malik A, Manson P, Elisseeff J. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng 2003;9:679-688.
12. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, Noh I, Lee SH, Park Y, Sun K. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 2007;28:1830-1837. (Pubitemid 46123539)
13. Wang DA, Williams CG, Yang F, Cher N, Lee H, Elisseeff JH. Bioresponsive phosphoester hydrogels for bone tissue engineering. Tissue Eng 2005;11:201-213. (Pubitemid 40515188)
14. Hudalla GA, Eng TS, Murphy WL. An approach to modulate degradation and mesenchymal stem cell behavior in poly(ethylene glycol) networks. Biomacromolecules 2008;9:842-849.
15. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-689. (Pubitemid 44233625)
16. Albrecht DR, Tsang VL, Sah RL, Bhatia SN. Photo- and electropatterning of hydrogel-encapsulated living cell arrays. Lab Chip 2005;5:111-118.
17. Koh WG, Itle LJ, Pishko MV. Molding of hydrogel microstructures to create multiphenotype cell microarrays. Anal Chem 2003;75:5783-5789.
18. Koh WG, Revzin A, Pishko MV. Poly(ethylene glycol) hydrogel microstructures encapsulating living cells. Langmuir 2002;18:2459-2462. (Pubitemid 35383811)
19. Ling Y, Rubin J, Deng Y, Huang C, Demirci U, Karp JM, Khademhosseini A. A cell-laden microfluidic hydrogel. Lab Chip 2007;7:756-762.
20. Jongpaiboonkit L, King WJ, Lyons GE, Paguirigan AL, Warrick JW, Beebe DJ, Murphy WL. An adaptable hydrogel array format for 3-dimensional cell culture and analysis. Biomaterials 2008;29:3346-3356.
21. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105. (Pubitemid 36683205)
22. Go MJ, Takenaka C, Ohgushi H. Effect of forced expression of basic fibroblast growth factor in human bone marrow-derived mesenchymal stromal cells. J Biochem 2007;142:741-748. (Pubitemid 351197708)
23. Ito T, Sawada R, Fujiwara Y, Seyama Y, Tsuchiya T. FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun 2007;359:108-114. (Pubitemid 46836675)
24. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006;24:462-471. (Pubitemid 44464816)
25. Schmidt A, Ladage D, Schinköthe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RHG, Staib P, Addicks K, Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 2006;24:1750-1758. (Pubitemid 44474188)
26. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997;138:4456-4462. (Pubitemid 27408494)
27. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005;203:398-409. (Pubitemid 40471774)
28. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-419. (Pubitemid 33022499)
29. Cruise GM, Scharp DS, Hubbell JA. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials 1998;19:1287-1294.
30. Lutolf MP, Tirelli N, Cerritelli S, Cavalli L, Hubbell JA. Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. Bioconjug Chem 2001;12:1051-1056. (Pubitemid 33136878)
31. Skaper SD, Kee WJ, Facci L, Macdonald G, Doherty P, Walsh FS. The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J Neurochem 2000;75:1520-1527.
32. Trudel S, Ely S, Farooqi Y, Affer M, Robbiani DF, Chesi M, Bergsagel PL. Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma. Blood 2004;103:3521-3528. (Pubitemid 38525687)
33. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard SR. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J 1998;17:5896-5904. (Pubitemid 28474784)
34. Bansal R, Magge S, Winkler S. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 2003;74:486-493. (Pubitemid 37352070)
35. Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 2006;24:2412-2419. (Pubitemid 44674301)
36. Khetan SK, Joshua S, Burdick A. Sequential crosslinking to control cellular spreading in 3-dimensional hydrogels. Soft Matter 2009;5:1601-1606.
37. Shihabuddin LS, Ray J, Gage FH. FGF-2 is sufficient to isolate progenitors found in the adult mammalian spinal cord. Exp Neurol 1997;148:577-586. (Pubitemid 28068850)
38. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2005;2:185-190. (Pubitemid 41122125)
39. Hentges S, Boyadjieva N, Sarkar DK. Transforming growth factor-beta 3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 2000;141:859-867. (Pubitemid 32260428)
40. Batas B, Jones HR, Chaudhuri JB. Studies of the hydrodynamic volume changes that occur during refolding of lysozyme using size-exclusion chromatography. J Chromatogr A 1997;766:109-119. (Pubitemid 27166338)
41. Onuma K, Kanzaki N, Kobayashi N. Association of calcium phosphate and fibroblast growth factor-2: A dynamic light scattering study. Macromol Biosci 2004;4:39-46. (Pubitemid 38209248)
42. Tanihara M, Suzuki Y, Yamamoto E, Noguchi A, Mizushima Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 2001;56:216-221. (Pubitemid 32520696)
43. Moscatelli D. Metabolism of receptor-bound and matrixbound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol 1988;107:753-759.
44. Rusnati M, Tanghetti E, Dellera P, Gualandris A, Presta M. Alpha(v)beta(3) integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol Biol Cell 1997;8:2449-2461.
45. Varas L, Ohlsson LB, Honeth G, Olsson A, Bengtsson T, Wiberg C, Bockermann R, Järnum S, Richter J, Pennington D, Johnstone B, Lundgren-Akerlund E, Kjellman C. Alpha 10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential. Stem Cells Dev 2007;16:965-978.
46. Connelly JT, Garcia AJ, Levenston ME. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. Biomaterials 2007;28:1071-1083.
47. Connelly JT, Garcia AJ, Levenston ME. Interactions between integrin ligand density and cytoskeletal integrity regulate BMSC chondrogenesis. J Cell Physiol 2008;217:145-154.
48. Rizzuto R, Carrington W, Tuft RA. Digital imaging microscopy of living cells. Trends Cell Biol 1998;8:288-292. (Pubitemid 28310227)
49. Tai G, Christodoulou I, Bishop AE, Polak JM. Use of green fluorescent fusion protein to track activation of the transcription factor osterix during early osteoblast differentiation. Biochem Biophys Res Commun 2005;333:1116-1122. (Pubitemid 40910119)
50. Osaki M, Tan L, Choy BK, Yoshida Y, Cheah KS, Auron PE, Goldring MB. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferongamma-mediated inhibition in human chondrocytes: Requirement for Stat1 alpha, Jak1 and Jak2. Biochem J 2003;369:103-115. (Pubitemid 36174130)
51. Abraham VC, Taylor DL, Haskins JR. High content screening applied to large-scale cell biology. Trends Biotechnol 2004;22:15-22.